Jpmorgan Chase & CO Natera, Inc. Call Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NTRA
# of Institutions
512Shares Held
120MCall Options Held
412KPut Options Held
270K-
Vanguard Group Inc Valley Forge, PA11.3MShares$1.43 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$858 Million0.02% of portfolio
-
Fred Alger Management, LLC New York, NY5.26MShares$667 Million2.83% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.46MShares$565 Million2.34% of portfolio
-
State Street Corp Boston, MA3.57MShares$453 Million0.02% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $12.3B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...